BIS: highest CDO issuance ever but slowed overall derivatives trading

Global issuance of funded collateralised debt obligations (CDOs) reached a record $489 billion in 2006, showing strong investor interest in structured products. Synthetic CDO issuance also surged last year, doubling to $450 billion from 2005 issuance levels, according to the latest Bank for International Settlements (BIS) Quarterly Review.

However, overall international derivatives trading on exchanges slowed in the fourth quarter of 2006, with a fall of 7% between October and December to $431 trillion of turnover in notional amounts of interest rate, equity index and currency contracts. This was caused by a seasonal tail-off in interest rate trading. Currency contracts, however, grew 19% to a record level of just under $5 trillion, due to strong trading in sterling and central European currencies.

Hedge funds’ returns were found to be partly driven by carry trade payoffs. BIS figures showed that speculative trading on yen weakness in futures traded in the US rose from the middle of 2006 to late February 2007, especially during yen depreciation. This is the first time the BIS has measured the effect of carry trades on the foreign exchange market.

However, BIS researchers Patrick McGuire and Christian Upper warned it was difficult to measure the size and importance of the trade, due to incomplete data on carry positions and trading activity. "Hedge fund returns appear to be sensitive to carry trade payoffs, but the results are far from conclusive," they wrote.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here